| 标题 |
FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells |
| 网址 | |
| DOI | |
| 其它 |
期刊:Biomedicine & Pharmacotherapy 作者:Betlem Mezquita; Marjorie Reyes‐Farias; Miquel Pons 出版日期:2024-09-02 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)